Advertisement

Topics

Affigen Company Profile

10:42 EDT 18th June 2019 | BioPortfolio

Affigen (www.affigen.com) develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers. The Company's growing team houses deep expertise in immuno-oncology, mass-personalized biomolecular engineering and complex therapeutic development, and is working to deliver a new class of therapeutics that maximize both anti-tumor activity and safety in patients with critically unmet medical needs. Affigen was founded in 2016 by Frameshift, a firm that ideates, translates and launches life sciences companies that have the potential to fundamentally shift the metabolic rate of the industry. The Company is headquartered in the Cortex Innovation District in St. Louis, Missouri.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Affigen

Affigen (www.affigen.com) develops tumor-identifying therapeutics that target cell lineage-specific tumor proteins in certain incurable cancers. The Company's growing team ...

More Information about "Affigen" on BioPortfolio

We have published hundreds of Affigen news stories on BioPortfolio along with dozens of Affigen Clinical Trials and PubMed Articles about Affigen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Affigen Companies in our database. You can also find out about relevant Affigen Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record